SynthesisFuture oncology (London, England)2026

Efficacy and safety of triple or dual therapies for metastatic hormone-sensitive prostate cancer: a systematic review and Bayesian network meta-analysis.

Jingqi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.